计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| D106380-1g |
1g |
现货 ![]() |
| |
| D106380-5g |
5g |
现货 ![]() |
| |
| D106380-25g |
25g |
现货 ![]() |
| |
| D106380-100g |
100g |
现货 ![]() |
| |
| D106380-500g |
500g |
现货 ![]() |
|
| 别名 | 3β-羟基-5-雄烯-17-酮 | 去氢表雄酮 | 普拉睾酮 | 脱氢异雄酮 | 雄素-5-烯-3β-醇-17-酮 | 脱氢表雄酮 | 去氢表雄酮 | 脱氢表雄甾酮 | 脱氢表雄至素酮 | 脱氢异雄酮 | 反式-脱氢异雄甾酮 | 反式-脱氢雄甾酮 |
|---|---|
| 英文别名 | DHEA | A14AA07 | NCGC00093802-06 | BCPE00002 | Prasterone [INN] | 3beta-Hydroxy-D5-androsten-17-one | 5-Dehydroepiandrosterone | 5-dehydro-Epiandrosterone | bmse000665 | Intrarosa | Lopac0_000368 | Biolaif (TN) | D5-Androsten-3b-ol-17-one | Prasterone [US |
| 规格或纯度 | Moligand™, ≥99% |
| 英文名称 | trans-Dehydroandrosterone(DHEA) |
| 生化机理 | GABAA 受体的负调节剂。肾上腺分泌的类固醇,具有雌激素和雄激素特性。 它转化为 5-雄烯二醇(一种有效的雌激素)可增强雌激素敏感性乳腺肿瘤的生长和存活率。在高浓度但生理有效的条件下,DHEA 抑制嗜铬细胞祖细胞的增殖并诱导多巴胺能分化。 脱氢雄激素(DHEA)是 GABAA 受体的负调节剂。它是肾上腺分泌的类固醇,具有雌激素和雄激素特性。 脱氢表雄酮(DHEA)转化为 5-雄烯二醇(一种有效的雌激素)可增强雌激素敏感性乳腺肿瘤的生长和存活率。 |
| 应用 | 去氢表雄酮用于制造甾体激素类药物的中间体,具有抗衰老及蛋白同化作用。 |
| 运输条件 | 常规运输 |
| 产品介绍 |
去氢表雄酮用于制造甾体激素类药物的中间体,具有抗衰老及蛋白同化作用。 |
| 纯度 | ≥99% |
| ALogP | 3.2 |
|---|
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| EC号 | 200-175-5 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | (3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one |
| INCHI | 1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14-,15-,16-,18-,19-/m0/s1 |
| InChi Key | FMGSKLZLMKYGDP-USOAJAOKSA-N |
| Smiles | CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C |
| Isomeric SMILES | C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)O)C |
| 分子量 | 288.43 |
| Beilstein号 | 2058110 |
| Reaxy-Rn | 1915231 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=1915231&ln= |
| 密度 | 1.12 |
|---|---|
| 熔点 | 146-151°C |
| 分子量 | 288.400 g/mol |
| XLogP3 | 3.200 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 2 |
| 可旋转键计数Rotatable Bond Count | 0 |
| 精确质量Exact Mass | 288.209 Da |
| 单同位素质量Monoisotopic Mass | 288.209 Da |
| 拓扑极表面积Topological Polar Surface Area | 37.300 Ų |
| 重原子数Heavy Atom Count | 21 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 508.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 6 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS07, GHS08, GHS09 |
|---|---|
| 信号词 | 危险 |
| 危险声明 |
H315: 引起皮肤刺激 H319: 引起严重眼睛刺激 H335: 可能引起呼吸道刺激 H360: 可能损害生育力或未出生的孩子 H362: 可能对母乳喂养的孩子造成伤害 H400: 对水生生物有剧毒 H410: 对水生生物有剧毒并具有长期持续影响 |
| 预防措施声明 |
P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。 P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P263: 避免在怀孕期间/哺乳期间接触。 P264: 处理后要彻底洗手。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P271: 仅在室外或通风良好的地方使用。 P273: 避免释放到环境中。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P321: 特殊处理(请参阅此标签上的...)。 P391: 收集溢出物 P302+P352: 如皮肤沾染:用水充分清洗。 P304+P340: 如误吸入:将人转移到空气新鲜处,保持呼吸舒适体位。 P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P362+P364: 脱掉沾污的衣服,清洗后方可重新使用。 P405: 密闭存放 P403+P233: 存放在通风良好的地方。保持容器密闭。 P501: 将内容物/容器处理到。。。 P203: 使用前,获取、阅读并遵守所有安全说明。 P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。 P318: 如果暴露或担心,请就医。 P337+P317: 如果眼睛刺激持续:寻求医疗帮助。 P332+P317: 如果出现皮肤刺激:请寻求医疗帮助。 P319: 如果你感到不适,请寻求医疗帮助。 |
| WGK Germany | 2 |
| RTECS | BV8396000 |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 | |
| 分析证书 | D106380 |
¥205.90
| 1. Guojuan Yi, Hanlu Zou, Tao Long, Tolbert Osire, Lin Wang, Xiaoyun Wei, Mengfei Long, Zhiming Rao, Guojian Liao. (2024) Novel cytochrome P450s for various hydroxylation of steroids from filamentous fungi. BIORESOURCE TECHNOLOGY, 394 (130244). [PMID:38145763] [10.1016/j.biortech.2023.130244] |
| 2. Nan Li, Juan Zheng, Lu-Dan Yu, Yuan-Jun Tong, Xinying Gong, Yu Hou, Guosheng Chen, Jianqiao Xu, Fang Zhu, Gangfeng Ouyang. (2024) Green, mildly synthesized bismuth-based MOF for extraction of polar glucocorticoids in environmental water. JOURNAL OF HAZARDOUS MATERIALS, 461 (132477). [PMID:37716268] [10.1016/j.jhazmat.2023.132477] |
| 3. Lifeng Ding, Lili Jiang, Ze Xing, Huixu Dai, Jingzan Wei. (2023) Map4k4 is up-regulated and modulates granulosa cell injury and oxidative stress in polycystic ovary syndrome via activating JNK/c-JUN pathway: An experimental study. INTERNATIONAL IMMUNOPHARMACOLOGY, 124 (110841). [PMID:37647682] [10.1016/j.intimp.2023.110841] |
| 4. Tingting Yang, Jiayu Yuan, Yuting Peng, Jiale Pang, Zhen Qiu, Shangxiu Chen, Yuhan Huang, Zhenzhou Jiang, Yilin Fan, Junjie Liu, Tao Wang, Xueyan Zhou, Sitong Qian, Jinfang Song, Yi Xu, Qian Lu, Xiaoxing Yin. (2023) Metformin: A promising clinical therapeutical approach for BPH treatment via inhibiting dysregulated steroid hormones-induced prostatic epithelial cells proliferation. Journal of Pharmaceutical Analysis, [PMID:38352949] [10.1016/j.jpha.2023.08.012] |
| 5. Jin-Bu Xu, Jin Bi, Peng Wen, Shi-Xing Miao, Xiao-Huan Li, Feng Gao. (2023) Synthesis and Cytotoxicity Evaluation of Dehydroepiandrosterone Derivatives by Iron-Catalyzed Stereoselective Hydroamination. CHEMICAL & PHARMACEUTICAL BULLETIN, 71 (5): (349-353). [PMID:36858603] [10.1248/cpb.c22-00857] |
| 6. Jing Cong, Mubai Li, Yu Wang, Hongli Ma, Xinming Yang, Jingshu Gao, Long Wang, Xiaoke Wu. (2023) Protective effects of electroacupuncture on polycystic ovary syndrome in rats: Down-regulating Alas2 to inhibit apoptosis, oxidative stress, and mitochondrial dysfunction in ovarian granulosa cells. TISSUE & CELL, 82 (102090). [PMID:37075681] [10.1016/j.tice.2023.102090] |
| 7. Ruosi Zhang, Mingdong Yao, Haidi Ma, Wenhai Xiao, Ying Wang, Yingjin Yuan. (2023) Modular Coculture to Reduce Substrate Competition and Off-Target Intermediates in Androstenedione Biosynthesis. ACS Synthetic Biology, 12 (3): (788–799). [PMID:36857753] [10.1021/acssynbio.2c00590] |
| 8. Ying Wang, Jiyu Yang, Yu Wang, Yao Chen, Yiran Wang, Hongying Kuang, Xiaoling Feng. (2023) Upregulation of TXNIP contributes to granulosa cell dysfunction in polycystic ovary syndrome via activation of the NLRP3 inflammasome. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 561 (111824). [PMID:36450326] [10.1016/j.mce.2022.111824] |
| 9. Jing Cong, Yuehui Zhang, Xinming Yang, Yu Wang, Hui He, Mengying Wang. (2022) Anti-polycystic ovary syndrome effect of electroacupuncture: IMD inhibits ER stress-mediated apoptosis and autophagy in granulosa cells. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 634 (159). [PMID:36244114] [10.1016/j.bbrc.2022.10.030] |
| 10. Ying Wang Yu Wang Yao Chen Qianqian Gao Lihui Hou Xiaoling Feng. (2022) HDAC5 inhibits ovarian angiogenesis in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 60 (3): (260-270). [PMID:36124413] [10.5603/FHC.a2022.0024] |
| 11. Xiao-San Li, Mao-Xun Yang, Yu-Hao Luo, He-Hui Zhan, Mei-Fang Chen, Yong-Mei Huang, Li Liu, Xue-Mei Yang. (2022) Design, Synthesis and Anticancer Activity of Novel Steroidal Derivatives with D-Ring Fused or Substituted N-Heterocyclic Systems. CHEMISTRY & BIODIVERSITY, 19 (10): (e202200648). [PMID:36043381] [10.1002/cbdv.202200648] |
| 12. Jing Xia, Shujuan Wu, Gengxiang Wu, Jing Yang. (2022) Inhibition of 8-oxoguanine DNA glycosylase (OGG1) expression suppresses polycystic ovarian syndrome via the NF-κB signaling pathway. Reproductive Biology, 22 (100679). [PMID:35961097] [10.1016/j.repbio.2022.100679] |
| 13. Ying-Li Cai, Feng Zhang, Xiu-Xiu Dou, Hua-Wu Zeng, Gao-Song Wu, Yan-Lin Liang, Xi-Ke Xu, Jing Zhao, Ji Ye, Wei-Dong Zhang. (2022) Integrated metabolomics and network pharmacology to reveal the therapeutic mechanism of Dingkun Pill on polycystic ovary syndrome. JOURNAL OF ETHNOPHARMACOLOGY, 295 (115442). [PMID:35688255] [10.1016/j.jep.2022.115442] |
| 14. Huiyi Yang, Qiyi He, Mingxia Lin, Li Ji, Leheng Zhang, Huanxin Xiao, Shijia Li, Qinglan Li, Xiping Cui, Suqing Zhao. (2022) Multifunctional Au@Pt@Ag NPs with color-photothermal-Raman properties for multimodal lateral flow immunoassay. JOURNAL OF HAZARDOUS MATERIALS, 435 (129082). [PMID:35650752] [10.1016/j.jhazmat.2022.129082] |
| 15. Susu Lin, Bingbing Ma, Qilin Gao, Jian Yang, Gang Lai, Runhao Lin, Bingxian Yang, Bing-Nan Han, Lian-Hua Xu. (2022) The 16α-Hydroxylation of Progesterone by Cytochrome P450 107X1 from Streptomyces avermitilis. CHEMISTRY & BIODIVERSITY, 19 (5): (e202200177). [PMID:35426465] [10.1002/cbdv.202200177] |
| 16. Yan Li, Jia Xu, Lingxia Li, Lu Bai, Yunping Wang, Jianfang Zhang, Haixu Wang. (2022) Inhibition of Nicotinamide adenine dinucleotide phosphate oxidase 4 attenuates cell apoptosis and oxidative stress in a rat model of polycystic ovary syndrome through the activation of Nrf-2/HO-1 signaling pathway. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 550 (111645). [PMID:35413388] [10.1016/j.mce.2022.111645] |
| 17. Huiyi Yang, Qiyi He, Junkang Pan, Mingxia Lin, Zhiting Lao, Qinglan Li, Xiping Cui, Suqing Zhao. (2022) PtCu nanocages with superior tetra-enzyme mimics for colorimetric sensing and fluorescent sensing dehydroepiandrosterone. SENSORS AND ACTUATORS B-CHEMICAL, 351 (130905). [10.1016/j.snb.2021.130905] |
| 18. Yang Huiyi, He Qiyi, Eremin Sergei A., Pan Junkang, Zou Yikui, Cui Xiping, Zhao Suqing. (2021) Fluorescence polarization immunoassay for rapid determination of dehydroepiandrosterone in human urine. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 413 (17): (4459-4469). [PMID:34137913] [10.1007/s00216-021-03403-7] |
| 19. Yang Huiyi, He Qiyi, Chen Yingshan, Shen Ding, Xiao Huanxin, Eremin Sergei A., Cui Xiping, Zhao Suqing. (2020) Platinum nanoflowers with peroxidase-like property in a dual immunoassay for dehydroepiandrosterone. MICROCHIMICA ACTA, 187 (11): (1-12). [PMID:33025211] [10.1007/s00604-020-04528-9] |
| 20. Jun Liu, Jinli Ding, Bing Qu, Jiuying Liu, Xiaojie Song, Qingli Suo, Aifen Zhou, Jing Yang. (2020) CircPSMC3 alleviates the symptoms of PCOS by sponging miR-296-3p and regulating PTEN expression. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 24 (18): (11001-11011). [PMID:32808450] [10.1111/jcmm.15747] |
| 21. Gengxiang Wu, Xue Hu, Jinli Ding, Jing Yang. (2020) The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats.. Journal of Ovarian Research, 13 (1): (57-57). [PMID:32386521] [10.1186/s13048-020-00650-7] |
| 22. Ling-Li Zheng, Guan Wen, Yun-Xin Yao, Xiao-Huan Li, Feng Gao. (2020) Design, Synthesis, and Anticancer Activity of Natural Product Hybrids With Paclitaxel Side Chain Inducing Apoptosis in Human Colon Cancer Cells. Natural Product Communications, [10.1177/1934578X20917298] |
| 23. Wu Gengxiang, Hu Xue, Ding Jinli, Yang Jing. (2019) Abnormal expression of HSP70 may contribute to PCOS pathology. Journal of Ovarian Research, 12 (1): (1-7). [PMID:31399035] [10.1186/s13048-019-0548-7] |
| 24. Zhou Dan-ni, Li Sai-jiao, Ding Jin-li, Yin Tai-lang, Yang Jing, Ye Hong. (2018) MIF May Participate in Pathogenesis of Polycystic Ovary Syndrome in Rats through MAPK Signalling Pathway. Current Medical Science, 38 (5): (853-860). [PMID:30341520] [10.1007/s11596-018-1953-7] |
| 25. Di Xu, Mengyun Wu, Xue Li, Mingyu Xia, Dongchun Liu, Yinghui Dai, Qing Yu, Bin Wu, Dong Wang. (2018) Cloning, prokaryotic expression and function of the Bufo bufo gargarizans 3β-hydroxysteroid dehydrogenase (3βHSD) gene. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 120 (673). [PMID:30170058] [10.1016/j.ijbiomac.2018.08.165] |
| 26. Xianzhi Qu, Jiyao Sheng, Luyan Shen, Jing Su, Yunjie Xu, Qi Xie, Yao Wu, Xuewen Zhang, Liankun Sun. (2017) Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS. PLoS One, 12 (3): (e0173712). [PMID:28301876] [10.1371/journal.pone.0173712] |
| 27. Zhuang Wu, Linlang Li, Long-Tai Zheng, Zhihong Xu, Lin Guo, Xuechu Zhen. (2015) Allosteric modulation of sigma-1 receptors by SKF83959 inhibits microglia-mediated inflammation. JOURNAL OF NEUROCHEMISTRY, 134 (5): (904-914). [PMID:26031312] [10.1111/jnc.13182] |
| 28. Teng-Fei Yuan,Juan Le,Yan Cui,Rui Peng,Shao-Ting Wang,Yan Li. (2018-09-17) An LC-MS/MS analysis for seven sex hormones in serum.. Journal of pharmaceutical and biomedical analysis, 162 (34-40). [PMID:30219597] |
| 29. Teng-Fei Yuan,Juan Le,Shao-Ting Wang,Yan Li. (2020-01-23) An LC/MS/MS method for analyzing the steroid metabolome with high accuracy and from small serum samples.. Journal of lipid research, 61 ((4)): (580-586). [PMID:31964762] |
| 30. Zhijing Song,Huanyu Gao,Wenchun Xie,Qing Sun,Kai Liang,Yan Li. (2020-12-29) Quantitative MALDI-MS assay of steroid hormones in plasma based on hydroxylamine derivatization.. Analytical biochemistry, 616 (114089-114089). [PMID:33359147] |
| 31. Yunjie Xu,Weinan Gao,Yong Zhang,Shanshan Wu,Yanan Liu,Xinyue Deng,Lili Xie,Jiayan Yang,Huimei Yu,Jing Su,Liankun Sun. (2018-07-18) ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.. International journal of oncology, 53 ((3)): (1055-1068). [PMID:30015875] |
| 32. Pingping Tang, Feiyu He. (2024) A Wearable Electrochemical Sensor Based on a Molecularly Imprinted Polymer Integrated with a Copper Benzene-1,3,5-Tricarboxylate Metal-Organic Framework for the On-Body Monitoring of Cortisol in Sweat. Polymers, 16 (16): (2289). [PMID:39204509] [10.3390/polym16162289] |
| 33. Juntong Li, Deliang Liu, Hengxia Zhao, Pengxiang Zhang, Fangying Cai, Huilin Li, Shufang Chu. (2024) Chinese medicine compound prescription HeQi San ameliorates chronic inflammatory states and modulates gut flora in dehydroepiandrosterone-induced polycystic ovary syndrome mouse model. INTERNATIONAL IMMUNOPHARMACOLOGY, 137 (112491). [PMID:38909499] [10.1016/j.intimp.2024.112491] |
| 34. Tan Cuiyu, Huang Shuqiang, Xu Liying, Zhang Tongtong, Yuan Xiaojun, Li Zhihong, Chen Miaoqi, Chen Cairong, Yan Qiuxia. (2024) Cross-talk between oxidative stress and lipid metabolism regulators reveals molecular clusters and immunological characterization in polycystic ovarian syndrome. Lipids in Health and Disease, 23 (1): (1-17). [PMID:39143634] [10.1186/s12944-024-02237-3] |
| 35. Hong Ling, Xiao Shan, Diao Lianghui, Lian Ruochun, Chen Cong, Zeng Yong, Liu Su. (2024) Decreased AMPK/SIRT1/PDK4 induced by androgen excess inhibits human endometrial stromal cell decidualization in PCOS. CELLULAR AND MOLECULAR LIFE SCIENCES, 81 (1): (1-24). [PMID:39080028] [10.1007/s00018-024-05362-5] |
| 36. Ming Zhao, Mengkai Hu, Rumeng Han, Chao Ye, Xiangfei Li, Tianwen Wang, Yan Liu, Zhenglian Xue, Kun Liu. (2024) Dynamics design of a non-natural transcription factor responding to androst-4-ene-3,17-dione. Synthetic and Systems Biotechnology, 9 (436). [PMID:38616975] [10.1016/j.synbio.2024.04.001] |
| 37. Mingming Wang, Jing Huang, Yue Shi, Richard Mprah, Huanhuan Ding, Shanshan Zhang, Cui Li. (2025) Exploring the efficacy of Wenshentiaojing decoction in PCOS: Network pharmacology and mouse model insights. BIOORGANIC CHEMISTRY, 154 (108089). [PMID:39742672] [10.1016/j.bioorg.2024.108089] |
| 38. Yating Xu, Li Ning, Yu Si, Xiu Li, Ruyue Wang, Qingling Ren. (2025) Metformin-mediated intestinal AMPK activation ameliorates PCOS through gut microbiota modulation and metabolic pathways. Frontiers in Endocrinology, 16 [PMID:40041289] [10.3389/fendo.2025.1526109] |
| 39. Wang Yong, Wang Wei, Wang Yu-Fei, Liu Cong-Jun, Su Wen-Hua, Gao Tian-Zeng, Li Jing-Jing, Li Wei-Shi. (2024) Synthesis, Structure, and Antitumor Activities of Dehydroepiandrosteronyl Derivatives with 1,2,3-Triazoles. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 50 (3): (982-990). [10.1134/S1068162024120343] |
| 40. Ting Wang, Xingliang Xiong, Na Xiao, Yizhong Yan, Xiaoyang Liu, Qi Xie, Xian Su, Maosheng Chen, Jing Peng, Siqi Wang, Hua Mei, Ge Lin, Fei Gong, Lamei Cheng. (2024) The therapeutic effect of anti-CD19 antibody on DHEA-induced PCOS mice. INTERNATIONAL IMMUNOPHARMACOLOGY, 130 (111711). [PMID:38428145] [10.1016/j.intimp.2024.111711] |
| 41. Yan Li, Hui Song, Jia Xu, Yunping Wang, Lu Bai, Haixu Wang, Jianfang Zhang. (2024) TIGAR relieves PCOS by inhibiting granulosa cell apoptosis and oxidative stress through activating Nrf2. MOLECULAR AND CELLULAR ENDOCRINOLOGY, (112381). [PMID:39341450] [10.1016/j.mce.2024.112381] |
| 42. Jing Wang, Lisha Li, Jing Zhou, Xinyao Pan, Qing Qi, Hongmei Sun, Ling Wang. (2024) Yishen Huatan Huoxue decoction and quercetin ameliorate decidualization dysfunction in polycystic ovary syndrome: A comprehensive investigation combining clinical trial and experimental studies. Drug Discoveries and Therapeutics, [PMID:38644207] [10.5582/ddt.2024.01003] |